191 related articles for article (PubMed ID: 36691839)
1. A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis.
Robson C; Tan B; Stuart R; Nicholls S; Rogers BA; Sandaradura I
J Antimicrob Chemother; 2023 Mar; 78(3):599-612. PubMed ID: 36691839
[TBL] [Abstract][Full Text] [Related]
2. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira J; Póvoa P
Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
[TBL] [Abstract][Full Text] [Related]
4. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
Falagas ME; Matthaiou DK; Bliziotis IA
J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
[TBL] [Abstract][Full Text] [Related]
5. Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients.
Smekal AK; Furebring M; Eliasson E; Lipcsey M
Sci Rep; 2022 Dec; 12(1):21891. PubMed ID: 36535989
[TBL] [Abstract][Full Text] [Related]
6. Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A Systematic Review and Meta-Regression of Bacterial Killing in Preclinical Infection Models.
Dhaese S; Heffernan A; Liu D; Abdul-Aziz MH; Stove V; Tam VH; Lipman J; Roberts JA; De Waele JJ
Clin Pharmacokinet; 2020 Oct; 59(10):1237-1250. PubMed ID: 32710435
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
[TBL] [Abstract][Full Text] [Related]
9. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
[TBL] [Abstract][Full Text] [Related]
10. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens.
Fuchs A; Li G; van den Anker JN; Bielicki J
Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814
[TBL] [Abstract][Full Text] [Related]
11. Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study.
Leon L; Guerci P; Pape E; Thilly N; Luc A; Germain A; Butin-Druoton AL; Losser MR; Birckener J; Scala-Bertola J; Novy E
J Antimicrob Chemother; 2020 Jan; 75(1):156-161. PubMed ID: 31599951
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients.
Sulaiman H; Roberts JA; Abdul-Aziz MH
Farm Hosp; 2022 Mar; 46(3):182-190. PubMed ID: 36183212
[TBL] [Abstract][Full Text] [Related]
13. Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Pai Mangalore R; Ashok A; Lee SJ; Romero L; Peel TN; Udy AA; Peleg AY
Clin Infect Dis; 2022 Nov; 75(10):1848-1860. PubMed ID: 35731853
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Antibiotics in Sub-Saharan African Patient Populations: A Systematic Review.
Bos JC; van Hest RM; Prins JM
Ther Drug Monit; 2017 Aug; 39(4):387-398. PubMed ID: 28703719
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
[TBL] [Abstract][Full Text] [Related]
16. Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia.
Alshaer MH; Maranchick N; Bai C; Maguigan KL; Shoulders B; Felton TW; Mathew SK; Mardini MT; Peloquin CA
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0056322. PubMed ID: 35699444
[TBL] [Abstract][Full Text] [Related]
17. Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base.
Abdul-Aziz MH; Portunato F; Roberts JA
Curr Opin Infect Dis; 2020 Dec; 33(6):501-510. PubMed ID: 33009140
[TBL] [Abstract][Full Text] [Related]
18. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting.
Pai Mangalore R; Peel TN; Udy AA; Peleg AY
J Antimicrob Chemother; 2023 Oct; 78(10):2395-2405. PubMed ID: 37466209
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR).
Guilhaumou R; Benaboud S; Bennis Y; Dahyot-Fizelier C; Dailly E; Gandia P; Goutelle S; Lefeuvre S; Mongardon N; Roger C; Scala-Bertola J; Lemaitre F; Garnier M
Crit Care; 2019 Mar; 23(1):104. PubMed ID: 30925922
[TBL] [Abstract][Full Text] [Related]
20. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
